Frost & Sullivan Commends Clarify Health for Leading the Population Health Management (PHM) Analytics Market with Its End-to-End Value-Based Payment Solution


According to Koustav Chatterjee, Global Program Manager at Frost & Sullivan, “Clarify Health has deep insights into population, market and performance, shaping its PHM solutions and services to meet the dynamic needs of customers. It collaborates with customers to set meaningful metrics and measure progress regularly, increasing customer value.”

The company’s software products help health plans and providers manage population health:

  • Clarify Care is cloud-based analytics software that accurately assesses provider performance and instantly identifies the most clinically relevant ways to improve the quality and efficiency of patient care delivery.
  • Clarify Populations is predictive analytics software that matches patients with the best-fit care programs to meet their clinical and social needs.
  • Clarify Contracts is a cloud-based software product that enables health plans to design value-based care contracts, manage financial performance, and digitize settlements.

Clarify facilitates a single source of truth by mapping patient journeys, leveraging over 300 million lives to deliver over 18 billion AI-powered predictions, bringing on-demand business intelligence within reach of all. It delivers unparalleled ROI through its industry-leading implementation methodology and customer success features. Its customer success organization ensures that the software delivers maximum value and improves performance.

“Clarify Health deliberately brings together healthcare expertise, big data efficiency, best-in-class clustering technology and cloud-based software to deliver on-demand analytics, revolutionizing healthcare and optimizing it for everyone. “said Chatterjee.

Each year, Frost & Sullivan presents this award to the company that demonstrates excellence in implementing strategies that proactively create value for its clients, thereby improving their return on investment. The award recognizes the company’s unique focus on high performance value creation, underscored by improved customer retention and customer expansion.

The Frost & Sullivan Best Practice Awards recognize companies in various regional and global markets for outstanding achievement and superior performance in leadership, technology innovation, customer service and strategic product development. Industry analysts benchmark market players and measure performance through in-depth interviews, analysis, and in-depth secondary research to identify industry best practices.

Access the Frost & Sullivan 2022 North America Customer Value Leadership Award report here.

About Frost & Sullivan
For six decades, Frost & Sullivan has been recognized worldwide for its role in helping investors, business leaders and governments navigate economic change and identify disruptive technologies, mega trends, new models commercial and corporate action, resulting in a continuous stream of growth opportunities to ensure future success. Contact us: start the discussion.

About Clarify Health
Clarify Health is a value-based payment and enterprise analytics platform company that empowers payers, providers and life sciences companies to deliver better care, therapies and outcomes with actionable insights on the patient journey. Clarify’s cloud-based business applications are built on the Clarify Atlas platform, which maps the journeys of over 300 million patients to deliver over 18 billion AI-based predictions and surface insights with speed and precision. Clarify’s products illuminate actionable opportunities to drive growth, optimize networks, improve care delivery, manage population health, maximize value-based care performance, and commercialize therapies. With Clarify, healthcare organizations can move from point solution and manual analysis to rapid, self-service generation of enterprise insights that pave the way for better care and outcomes. To learn more, visit

Lindsey Whitaker
Phone. : 1.210.477.8457
E: [email protected]

SOURCE Frost & Sullivan


Comments are closed.